4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000048
President & COO sold 27,097 shares at an average $16.27 ($440,801)
- President & COO acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2024-08-16 | Option exercise 10b5-1 | +20,000 | $1.74 | $34,800 | 157,204 | D |
| Dowden Nathan J President & COO | 2024-08-16 | Sale 10b5-1 | −26,595 | $16.26 | $432,419 | 130,609 | D |
| Dowden Nathan J President & COO | 2024-08-16 | Sale 10b5-1 | −502 | $16.70 | $8,382 | 130,107 | D |
| Derivatives | |||||||
| Dowden Nathan J President & COO | 2024-08-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 64,831 | D | ||
| Open-market sales · 27,097 sh · avg $16.27 · $440,801 | |||||||
Loading xslF345X05/wk-form4_1724186017.xml…